Insights into epileptogenesis from post-traumatic epilepsy.
Journal
Nature reviews. Neurology
ISSN: 1759-4766
Titre abrégé: Nat Rev Neurol
Pays: England
ID NLM: 101500072
Informations de publication
Date de publication:
03 Apr 2024
03 Apr 2024
Historique:
accepted:
07
03
2024
medline:
4
4
2024
pubmed:
4
4
2024
entrez:
3
4
2024
Statut:
aheadofprint
Résumé
Post-traumatic epilepsy (PTE) accounts for 5% of all epilepsies. The incidence of PTE after traumatic brain injury (TBI) depends on the severity of injury, approaching one in three in groups with the most severe injuries. The repeated seizures that characterize PTE impair neurological recovery and increase the risk of poor outcomes after TBI. Given this high risk of recurrent seizures and the relatively short latency period for their development after injury, PTE serves as a model disease to understand human epileptogenesis and trial novel anti-epileptogenic therapies. Epileptogenesis is the process whereby previously normal brain tissue becomes prone to recurrent abnormal electrical activity, ultimately resulting in seizures. In this Review, we describe the clinical course of PTE and highlight promising research into epileptogenesis and treatment using animal models of PTE. Clinical, imaging, EEG and fluid biomarkers are being developed to aid the identification of patients at high risk of PTE who might benefit from anti-epileptogenic therapies. Studies in preclinical models of PTE have identified tractable pathways and novel therapeutic strategies that can potentially prevent epilepsy, which remain to be validated in humans. In addition to improving outcomes after TBI, advances in PTE research are likely to provide therapeutic insights that are relevant to all epilepsies.
Identifiants
pubmed: 38570704
doi: 10.1038/s41582-024-00954-y
pii: 10.1038/s41582-024-00954-y
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Nature Limited.
Références
Popescu, C., Anghelescu, A., Daia, C. & Onose, G. Actual data on epidemiological evolution and prevention endeavours regarding traumatic brain injury. J. Med Life 8, 272–277 (2015).
pubmed: 26351526
pmcid: 4556905
Frieden, T. R., Houry, D. & Baldwin, G. Report to Congress on traumatic brain injury in the United States: epidemiology and rehabilitation. Centers for Disease Control and Prevention. https://www.cdc.gov/traumaticbraininjury/pdf/TBI_Report_to_Congress_Epi_and_Rehab-a.pdf (2015).
GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 56–87 (2019).
doi: 10.1016/S1474-4422(18)30415-0
Farrell, J. S., Wolff, M. D. & Teskey, G. C. Neurodegeneration and pathology in epilepsy: clinical and basic perspectives. Adv. Neurobiol. 15, 317–334 (2017).
pubmed: 28674987
doi: 10.1007/978-3-319-57193-5_12
Sharma, R. et al. Neuroinflammation in post-traumatic epilepsy: pathophysiology and tractable therapeutic targets. Brain Sci. 9, 318 (2019).
pubmed: 31717556
pmcid: 6895909
doi: 10.3390/brainsci9110318
Pease, M. et al. Association of posttraumatic epilepsy with long-term functional outcomes in individuals with severe traumatic brain injury. Neurology 100, e1967–e1975 (2023).
pubmed: 36948595
doi: 10.1212/WNL.0000000000207183
Burke, J. et al. Association of posttraumatic epilepsy with 1-year outcomes after traumatic brain injury. JAMA Netw. Open 4, e2140191 (2021).
pubmed: 34964854
pmcid: 8717106
doi: 10.1001/jamanetworkopen.2021.40191
Fordington, S. & Manford, M. A review of seizures and epilepsy following traumatic brain injury. J. Neurol. 267, 3105–3111 (2020).
pubmed: 32444981
pmcid: 7501105
doi: 10.1007/s00415-020-09926-w
Lucke-Wold, B. P. et al. Traumatic brain injury and epilepsy: underlying mechanisms leading to seizure. Seizure 33, 13–23 (2015).
pubmed: 26519659
doi: 10.1016/j.seizure.2015.10.002
Annegers, J. F., Hauser, W. A., Coan, S. P. & Rocca, W. A. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 338, 20–24 (1998).
pubmed: 9414327
doi: 10.1056/NEJM199801013380104
Pease, M. et al. Risk factors and incidence of epilepsy after severe traumatic brain injury. Ann. Neurol. 92, 663–669 (2022).
pubmed: 35713346
pmcid: 9489614
doi: 10.1002/ana.26443
Schmidt, D., Friedman, D. & Dichter, M. A. Anti-epileptogenic clinical trial designs in epilepsy: issues and options. Neurotherapeutics 11, 401–411 (2014).
pubmed: 24420312
pmcid: 3996121
doi: 10.1007/s13311-013-0252-z
Pitkänen, A., Lukasiuk, K., Dudek, F. E. & Staley, K. J. Epileptogenesis. Cold Spring Harb. Perspect. Med. 5, a022822 (2015).
pubmed: 26385090
pmcid: 4588129
doi: 10.1101/cshperspect.a022822
Löscher, W., Potschka, H., Sisodiya, S. M. & Vezzani, A. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol. Rev. 72, 606–638 (2020).
pubmed: 32540959
pmcid: 7300324
doi: 10.1124/pr.120.019539
Kehne, J. H., Klein, B. D., Raeissi, S. & Sharma, S. The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP). Neurochem. Res. 42, 1894–1903 (2017).
pubmed: 28462454
pmcid: 5504134
doi: 10.1007/s11064-017-2275-z
French, J. A. et al. Antiepileptogenesis and disease modification: clinical and regulatory issues. Epilepsia Open 6, 483–492 (2021).
pubmed: 34270884
pmcid: 8408600
doi: 10.1002/epi4.12526
Löscher, W. & Schmidt, D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52, 657–678 (2011).
pubmed: 21426333
doi: 10.1111/j.1528-1167.2011.03024.x
World Health Organization. Epilepsy: a public health imperative. WHO. https://iris.who.int/bitstream/handle/10665/325440/WHO-MSD-MER-19.2-eng.pdf (2019).
Gugger, J. J. et al. Multimodal quality of life assessment in post-9/11 veterans with epilepsy: impact of drug resistance, traumatic brain injury, and comorbidity. Neurology 98, E1761–E1770 (2022).
pubmed: 35387856
pmcid: 9071370
doi: 10.1212/WNL.0000000000200146
Raymont, V. et al. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology 75, 224–229 (2010).
pubmed: 20644150
pmcid: 2906177
doi: 10.1212/WNL.0b013e3181e8e6d0
Vespa, P. M. et al. The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: study design and protocol. Neurobiol. Dis. 123, 110–114 (2019).
pubmed: 30048805
doi: 10.1016/j.nbd.2018.07.025
Saletti, P. G. et al. Tau phosphorylation patterns in the rat cerebral cortex after traumatic brain injury and sodium selenate effects: an Epibios4rx Project 2 study. J. Neurotrauma 41, 222–243 (2024).
doi: 10.1089/neu.2022.0219
Saletti, P. G. et al. Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam. Epilepsia Open 8, 586–608 (2023).
pubmed: 37026764
pmcid: 10235584
doi: 10.1002/epi4.12738
Engel, J. J. Epileptogenesis, traumatic brain injury, and biomarkers. Neurobiol. Dis. 123, 3–7 (2019).
pubmed: 29625256
doi: 10.1016/j.nbd.2018.04.002
Correa, D. J. et al. Applying participatory action research in traumatic brain injury studies to prevent post-traumatic epilepsy. Neurobiol. Dis. 123, 137–144 (2019).
pubmed: 30031158
doi: 10.1016/j.nbd.2018.07.007
Duncan, D. et al. Big data sharing and analysis to advance research in post-traumatic epilepsy. Neurobiol. Dis. 123, 127–136 (2019).
pubmed: 29864492
doi: 10.1016/j.nbd.2018.05.026
Christensen, J. The epidemiology of posttraumatic epilepsy. Semin. Neurol. 35, 218–222 (2015).
pubmed: 26060901
doi: 10.1055/s-0035-1552923
Thapa, A. et al. Post-traumatic seizures — a prospective study from a tertiary level trauma center in a developing country. Seizure 19, 211–216 (2010).
pubmed: 20202866
doi: 10.1016/j.seizure.2010.02.004
Ritter, A. C. et al. Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a Traumatic Brain Injury Model Systems Study. Epilepsia 57, 1968–1977 (2016).
pubmed: 27739577
doi: 10.1111/epi.13582
Haltiner, A. M., Temkin, N. R. & Dikmen, S. S. Risk of seizure recurrence after the first late posttraumatic seizure. Arch. Phys. Med. Rehabil. 78, 835–840 (1997).
pubmed: 9344302
doi: 10.1016/S0003-9993(97)90196-9
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W. & Newton, C. R. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 51, 883–890 (2010).
pubmed: 20067507
pmcid: 3410521
doi: 10.1111/j.1528-1167.2009.02481.x
Thijs, R. D., Surges, R., O’Brien, T. J. & Sander, J. W. Epilepsy in adults. Lancet 393, 689–701 (2019).
pubmed: 30686584
doi: 10.1016/S0140-6736(18)32596-0
Angeleri, F. et al. Posttraumatic epilepsy risk factors: one-year prospective study after head injury. Epilepsia 40, 1222–1230 (1999).
pubmed: 10487184
doi: 10.1111/j.1528-1157.1999.tb00850.x
Englander, J. et al. Analyzing risk factors for late posttraumatic seizures: a prospective, multicenter investigation. Arch. Phys. Med. Rehabil. 84, 365–373 (2003).
pubmed: 12638104
doi: 10.1053/apmr.2003.50022
Ferguson, P. L. et al. A population-based study of risk of epilepsy after hospitalization for traumatic brain injury. Epilepsia 51, 891–898 (2010).
pubmed: 19845734
doi: 10.1111/j.1528-1167.2009.02384.x
Laing, J. et al. Risk factors and prognosis of early posttraumatic seizures in moderate to severe traumatic brain injury. JAMA Neurol. 79, 334–341 (2022).
pubmed: 35188950
pmcid: 8861899
doi: 10.1001/jamaneurol.2021.5420
Christensen, J. et al. Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study. Lancet 373, 1105–1110 (2009).
pubmed: 19233461
doi: 10.1016/S0140-6736(09)60214-2
Karlander, M., Ljungqvist, J. & Zelano, J. Post-traumatic epilepsy in adults: a nationwide register-based study. J. Neurol. Neurosurg. Psychiatry 92, 617–621 (2021).
pubmed: 33687971
doi: 10.1136/jnnp-2020-325382
DeGrauw, X. et al. Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: an analysis of insurance claims data, 2004–2014. Epilepsy Res. 146, 41–49 (2019).
doi: 10.1016/j.eplepsyres.2018.07.012
Annegers, J. F. et al. Seizures after head trauma: a population study. Neurology 30, 683–689 (1980).
pubmed: 7190235
doi: 10.1212/WNL.30.7.683
Mahler, B. et al. Unprovoked seizures after traumatic brain injury: a population-based case–control study. Epilepsia 56, 1438–1444 (2015).
pubmed: 26332184
doi: 10.1111/epi.13096
Santos, S., Murphy, G., Baxter, K. & Robinson, K. M. Organisational factors affecting the quality of hospital clinical coding. Heal. Inf. Manag. 37, 25–37 (2008).
O’Malley, K. J. et al. Measuring diagnoses: ICD code accuracy. Health Serv. Res. 40, 1620–1639 (2005).
pubmed: 16178999
pmcid: 1361216
doi: 10.1111/j.1475-6773.2005.00444.x
Langlois, J. A., Rutland-Brown, W. & Wald, M. M. The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21, 375–378 (2006).
pubmed: 16983222
doi: 10.1097/00001199-200609000-00001
Pugh, M. J. V. et al. The prevalence of epilepsy and association with traumatic brain injury in veterans of the Afghanistan and Iraq wars. J. Head Trauma Rehabil. 30, 29–37 (2015).
pubmed: 24695268
doi: 10.1097/HTR.0000000000000045
Lolk, K., Dreier, J. W. & Christensen, J. Repeated traumatic brain injury and risk of epilepsy: a Danish nationwide cohort study. Brain 144, 875–884 (2021).
pubmed: 33439977
doi: 10.1093/brain/awaa448
Tubi, M. A. et al. Early seizures and temporal lobe trauma predict post-traumatic epilepsy: a longitudinal study. Neurobiol. Dis. 123, 115–121 (2019).
pubmed: 29859872
doi: 10.1016/j.nbd.2018.05.014
Salazar, A. M. et al. Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 35, 1406–1414 (1985).
pubmed: 3929158
doi: 10.1212/WNL.35.10.1406
The World Bank. World bank country and lending groups. Worldbank.org. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (2023).
Ogunrin, O. A. & Adeyekun, A. A. Profile of post-traumatic epilepsy in Benin City, Nigeria. West Afr. J. Med. 29, 153–157 (2011).
doi: 10.4314/wajm.v29i3.68212
Rabiu, T. B. & Adetunmbi, B. Posttraumatic seizures in a rural Nigerian neurosurgical service. World Neurosurg. 104, 367–371 (2017).
pubmed: 28461273
doi: 10.1016/j.wneu.2017.04.133
Wang, X. P. et al. Development and external validation of a predictive nomogram model of posttraumatic epilepsy: a retrospective analysis. Seizure 88, 36–44 (2021).
pubmed: 33812306
doi: 10.1016/j.seizure.2021.03.023
Espinosa-Jovel, C., Toledano, R., Aledo-Serrano, Á., García-Morales, I. & Gil-Nagel, A. Epidemiological profile of epilepsy in low income populations. Seizure 56, 67–72 (2018).
pubmed: 29453113
doi: 10.1016/j.seizure.2018.02.002
Gennarelli, T., Champion, H., Copes, W. & Sacco, W. Comparison of mortality, morbidity, and severity of 59,713 head injured patients with 114,447 patients with extracranial injuries. J. Trauma 37, 962–968 (1994).
pubmed: 7996612
doi: 10.1097/00005373-199412000-00016
Eagle, S. R., Pease, M., Nwachuku, E., Deng, H. & Okonkwo, D. O. Prognostic models for traumatic brain injury have good discrimination but poor overall model performance for predicting mortality and unfavorable outcomes. Neurosurgery 92, 137–143 (2023).
pubmed: 36173200
doi: 10.1227/neu.0000000000002150
Eagle, S. R. et al. Performance of CRASH and IMPACT prognostic models for traumatic brain injury at 12 and 24 months post-injury. Neurotrauma Rep. 4, 118–123 (2023).
pubmed: 36895818
pmcid: 9989509
doi: 10.1089/neur.2022.0082
Hanna Siig Hausted, J. F. N. & Odgaard, L. Epilepsy after severe traumatic brain injury: frequency and injury severity. Brain Inj. 34, 889–894 (2020).
pubmed: 32506958
doi: 10.1080/02699052.2020.1763467
Ritter, A. C. et al. Prognostic models for predicting posttraumatic seizures during acute hospitalization, and at 1 and 2 years following traumatic brain injury. Epilepsia 57, 1503–1514 (2016).
pubmed: 27430564
doi: 10.1111/epi.13470
Xu, T. et al. Risk factors for posttraumatic epilepsy: a systematic review and meta-analysis. Epilepsy Behav. 67, 1–6 (2017).
pubmed: 28076834
doi: 10.1016/j.yebeh.2016.10.026
Temkin, N. R. Risk factors for posttraumatic seizures in adults. Epilepsia 44, 18–20 (2003).
pubmed: 14511390
doi: 10.1046/j.1528-1157.44.s10.6.x
Arefan, D., Pease, M., Eagle, S. R., Okonkwo, D. O. & Wu, S. Comparison of machine learning models to predict long-term outcomes after severe traumatic brain injury. Neurosurg. Focus 54, E14 (2023).
pubmed: 37552699
doi: 10.3171/2023.3.FOCUS2376
Dijkland, S. A. et al. Prognosis in moderate and severe traumatic brain injury: a systematic review of contemporary models and validation studies. J. Neurotrauma 37, 1–13 (2020).
pubmed: 31099301
doi: 10.1089/neu.2019.6401
Steyerberg, E. W. et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 5, 1251–1261 (2008).
doi: 10.1371/journal.pmed.0050165
Immonen, R. et al. Imaging biomarkers of epileptogenecity after traumatic brain injury — preclinical frontiers. Neurobiol. Dis. 123, 75–85 (2019).
pubmed: 30321600
doi: 10.1016/j.nbd.2018.10.008
Garner, R. et al. Imaging biomarkers of posttraumatic epileptogenesis. Epilepsia 60, 2151–2162 (2019).
pubmed: 31595501
pmcid: 6842410
doi: 10.1111/epi.16357
Prince, D. A. et al. Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis. Epilepsia 50, 30–40 (2009).
pubmed: 19187292
pmcid: 2710960
doi: 10.1111/j.1528-1167.2008.02008.x
Jennett, W. B. & Lewin, W. Traumatic epilepsy after closed head injuries. J. Neurol. Neurosurg. Psychiatry 23, 295–301 (1960).
pubmed: 13789853
pmcid: 497428
doi: 10.1136/jnnp.23.4.295
Al-Haddad, S. A. & Kirollos, R. A 5-year study of the outcome of surgically treated depressed skull fractures. Ann. R. Coll. Surg. Engl. 84, 196–200 (2002).
pubmed: 12092875
pmcid: 2503833
De Reuck, J. Risk factors for late-onset seizures related to cerebral contusions in adults with a moderate traumatic brain injury. Clin. Neurol. Neurosurg. 113, 469–471 (2011).
pubmed: 21371813
doi: 10.1016/j.clineuro.2011.02.004
La Rocca, M. et al. Distribution and volume analysis of early hemorrhagic contusions by MRI after traumatic brain injury: a preliminary report of the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx). Brain Imaging Behav. 15, 2804–2812 (2021).
pubmed: 34985618
doi: 10.1007/s11682-021-00603-8
Messori, A., Polonara, G., Carle, F., Gesuita, R. & Salvolini, U. Predicting posttraumatic epilepsy with MRI: prospective longitudinal morphologic study in adults. Epilepsia 46, 1472–1481 (2005).
pubmed: 16146443
doi: 10.1111/j.1528-1167.2005.34004.x
Gupta, P. K. et al. Subtypes of post-traumatic epilepsy: clinical, electrophysiological, and imaging features. J. Neurotrauma 31, 1439–1443 (2014).
pubmed: 24693960
pmcid: 4132580
doi: 10.1089/neu.2013.3221
Won, S. Y. et al. A systematic review of epileptic seizures in adults with subdural haematomas. Seizure 45, 28–35 (2017).
pubmed: 27914224
doi: 10.1016/j.seizure.2016.11.017
La Rocca, M. et al. Multiplex networks to characterize seizure development in traumatic brain injury patients. Front. Neurosci. 14, 591662 (2020).
pubmed: 33328863
pmcid: 7734183
doi: 10.3389/fnins.2020.591662
Lutkenhoff, E. S. et al. Early brain biomarkers of post-traumatic seizures: initial report of the multicentre epilepsy bioinformatics study for antiepileptogenic therapy (EpiBioS4Rx) prospective study. J. Neurol. Neurosurg. Psychiatry 91, 1154–1157 (2020).
pubmed: 32848013
doi: 10.1136/jnnp-2020-322780
Manninen, E. et al. Acute thalamic damage as a prognostic biomarker for post-traumatic epileptogenesis. Epilepsia 62, 1852–1864 (2021).
pubmed: 34245005
doi: 10.1111/epi.16986
Graham, N. S. N., Cole, J. H., Bourke, N. J., Schott, J. M. & Sharp, D. J. Distinct patterns of neurodegeneration after TBI and in Alzheimer’s disease. Alzheimers Dement. 19, 3065–3077 (2023).
pubmed: 36696255
doi: 10.1002/alz.12934
Dinkel, J. et al. Long-term white matter changes after severe traumatic brain injury: a 5-year prospective cohort. Am. J. Neuroradiol. 35, 23–29 (2014).
pubmed: 23846796
pmcid: 7966468
doi: 10.3174/ajnr.A3616
Zelano, J. & Westman, G. Epilepsy after brain infection in adults. Neurology 95, e3213–e3220 (2020).
pubmed: 32989110
doi: 10.1212/WNL.0000000000010954
Yu, T., Liu, X., Sun, L., Wu, J. & Wang, Q. Clinical characteristics of post-traumatic epilepsy and the factors affecting the latency of PTE. BMC Neurol. 21, 301 (2021).
pubmed: 34348691
pmcid: 8340486
doi: 10.1186/s12883-021-02273-x
Candy, N., Tsimiklis, C., Poonnoose, S. & Trivedi, R. The use of antiepileptic medication in early post traumatic seizure prophylaxis at a single institution. J. Clin. Neurosci. 69, 198–205 (2019).
pubmed: 31451375
doi: 10.1016/j.jocn.2019.07.066
DJohn, J., Ibrahim, R., Patel, P., DeHoff, K. & Kolbe, N. Administration of levetiracetam in traumatic brain injury: is it warranted? Cureus 12, e9117 (2020).
pubmed: 32789060
pmcid: 7417124
Pease, M. et al. Multicenter and prospective trial of anti-epileptics for early seizure prevention in mild traumatic brain injury with a positive computed tomography scan. Surg. Neurol. Int. 13, 241 (2022).
pubmed: 35855176
pmcid: 9282794
doi: 10.25259/SNI_38_2022
Lee, S. T., Lui, T. N., Wong, C. W., Yeh, Y. S. & Tzaan, W. C. Early seizures after moderate closed head injury. Acta Neurochir. 137, 151–154 (1995).
pubmed: 8789655
doi: 10.1007/BF02187187
Temkin, N. R. et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N. Engl. J. Med. 323, 497–502 (1990).
pubmed: 2115976
doi: 10.1056/NEJM199008233230801
Gugger, J. J. & Diaz-Arrastia, R. Early posttraumatic seizures — putting things in perspective. JAMA Neurol. 79, 325–326 (2022).
pubmed: 35188948
doi: 10.1001/jamaneurol.2021.5419
Jennett, B. Early traumatic epilepsy: incidence and significance after nonmissile injuries. Arch. Neurol. 30, 394–398 (1974).
pubmed: 4207011
doi: 10.1001/archneur.1974.00490350052008
Glaser, A. C. et al. The effect of antiseizure medication administration on mortality and early posttraumatic seizures in critically ill older adults with traumatic brain injury. Neurocrit. Care 37, 538–546 (2022).
pubmed: 35641806
doi: 10.1007/s12028-022-01531-1
Zhao, Y., Wu, H., Wang, X., Li, J. & Zhang, S. Clinical epidemiology of posttraumatic epilepsy in a group of Chinese patients. Seizure 21, 322–326 (2012).
pubmed: 22425008
doi: 10.1016/j.seizure.2012.02.007
Bakr, A. & Belli, A. A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury. Br. J. Neurosurg. 32, 237–244 (2018).
pubmed: 29688078
doi: 10.1080/02688697.2018.1464118
Carney, N. et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 80, 6–15 (2017).
pubmed: 27654000
doi: 10.1227/NEU.0000000000001432
Wilson, C. D. et al. Early and late posttraumatic epilepsy in the setting of traumatic brain injury: a meta-analysis and review of antiepileptic management. World Neurosurg. 110, e901–e906 (2018).
pubmed: 29196247
doi: 10.1016/j.wneu.2017.11.116
Sundararajan, K., Milne, D., Edwards, S., Chapman, M. J. & Shakib, S. Anti-seizure prophylaxis in critically ill patients with traumatic brain injury in an intensive care unit. Anaesth. Intensive Care 43, 646–651 (2015).
pubmed: 26310417
doi: 10.1177/0310057X1504300515
Sun, Y. et al. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury. Scand. J. Trauma Resusc. Emerg. Med 25, 85 (2017).
pubmed: 28841884
pmcid: 5574127
doi: 10.1186/s13049-017-0382-0
Temkin, N. R. et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J. Neurosurg. 91, 593–600 (1999).
pubmed: 10507380
doi: 10.3171/jns.1999.91.4.0593
Wang, B. C. et al. Comparative efficacy of prophylactic anticonvulsant drugs following traumatic brain injury: a systematic review and network meta-analysis of randomized controlled trials. PLoS ONE 17, e0265932 (2022).
pubmed: 35358219
pmcid: 8970384
doi: 10.1371/journal.pone.0265932
Kwon, S. J. et al. Lacosamide versus phenytoin for the prevention of early post traumatic seizures. J. Crit. Care 50, 50–53 (2019).
pubmed: 30471561
doi: 10.1016/j.jcrc.2018.11.010
Herman, S. T. et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J. Clin. Neurophysiol. 32, 87–95 (2015).
pubmed: 25626778
pmcid: 4435533
doi: 10.1097/WNP.0000000000000166
Vespa, P. et al. Metabolic crisis occurs with seizures and periodic discharges after brain trauma. Ann. Neurol. 79, 579–590 (2016).
pubmed: 26814699
doi: 10.1002/ana.24606
Khor, D. et al. Early seizure prophylaxis in traumatic brain injuries revisited: a prospective observational study. World J. Surg. 42, 1727–1732 (2018).
pubmed: 29159600
doi: 10.1007/s00268-017-4373-0
Inglet, S. et al. Seizure prophylaxis in patients with traumatic brain injury: a single-center study. Cureus 8, 6–8 (2016).
Hazama, A. et al. The effect of Keppra prophylaxis on the incidence of early onset, post-traumatic brain injury seizures. Cureus 10, e2674 (2018).
pubmed: 30050729
pmcid: 6059528
Pingue, V., Mele, C. & Nardone, A. Post-traumatic seizures and antiepileptic therapy as predictors of the functional outcome in patients with traumatic brain injury. Sci. Rep. 11, 4708 (2021).
pubmed: 33633297
pmcid: 7907376
doi: 10.1038/s41598-021-84203-y
Zaccara, G. et al. Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies. Br. J. Clin. Pharm. 83, 1873–1879 (2017).
doi: 10.1111/bcp.13296
Carpay, J. A., Aldenkamp, A. P. & van Donselaar, C. A. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 14, 198–206 (2005).
pubmed: 15797355
doi: 10.1016/j.seizure.2005.01.008
Lu, X. & Wang, X. Hyponatremia induced by antiepileptic drugs in patients with epilepsy. Expert Opin. Drug Saf. 16, 77–87 (2017).
pubmed: 27737595
doi: 10.1080/14740338.2017.1248399
Aarabi, B., Taghipour, M., Haghnegahdar, A., Farokhi, M. & Mobley, L. Prognostic factors in the occurrence of posttraumatic epilepsy after penetrating head injury suffered during military service. Neurosurg. Focus 8, e1 (2000).
pubmed: 16906697
doi: 10.3171/foc.2000.8.1.155
Galanopoulou, A. S. et al. Antiepileptogenesis and disease modification: progress, challenges, and the path forward — Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop. Epilepsia Open 6, 276–296 (2021).
pubmed: 34033232
pmcid: 8166793
doi: 10.1002/epi4.12490
Pingue, V. et al. Impact of seizures and their prophylaxis with antiepileptic drugs on rehabilitation course of patients with traumatic or hemorrhagic brain injury. Front. Neurol. 13, 1060008 (2022).
pubmed: 36438966
pmcid: 9691976
doi: 10.3389/fneur.2022.1060008
Pugh, M. J. et al. The military injuries: understanding post-traumatic epilepsy study: understanding relationships among lifetime traumatic brain injury history, epilepsy, and quality of life. J. Neurotrauma 38, 2841–2850 (2021).
pubmed: 34353118
pmcid: 8820288
doi: 10.1089/neu.2021.0015
Juengst, S. B. et al. Post-traumatic epilepsy associations with mental health outcomes in the first two years after moderate to severe TBI: a TBI Model Systems analysis. Epilepsy Behav. 73, 240–246 (2017).
pubmed: 28658654
doi: 10.1016/j.yebeh.2017.06.001
Mazzini, L. et al. Posttraumatic epilepsy: neuroradiologic and neuropsychological assessment of long-term outcome. Epilepsia 44, 569–574 (2003).
pubmed: 12681007
doi: 10.1046/j.1528-1157.2003.34902.x
Semple, B. D., Zamani, A., Rayner, G., Shultz, S. R. & Jones, N. C. Affective, neurocognitive and psychosocial disorders associated with traumatic brain injury and post-traumatic epilepsy. Neurobiol. Dis. 123, 27–41 (2020).
doi: 10.1016/j.nbd.2018.07.018
Ngadimon, I. W. et al. An interplay between post-traumatic epilepsy and associated cognitive decline: a systematic review. Front. Neurol. 13, 827571 (2022).
pubmed: 35280285
pmcid: 8908100
doi: 10.3389/fneur.2022.827571
Mukherjee, S. et al. Neuroinflammatory mechanisms of post-traumatic epilepsy. J. Neuroinflammation 17, 193 (2020).
pubmed: 32552898
pmcid: 7301453
doi: 10.1186/s12974-020-01854-w
La Rocca, M. et al. Functional connectivity alterations in traumatic brain injury patients with late seizures. Neurobiol. Dis. 179, 106053 (2023).
pubmed: 36871641
doi: 10.1016/j.nbd.2023.106053
Pease, M. et al. Outcome prediction in patients with severe traumatic brain injury using deep learning from head CT scans. Radiology 304, 385–394 (2022).
pubmed: 35471108
doi: 10.1148/radiol.212181
Lutkenhoff, E. S. et al. The subcortical basis of outcome and cognitive impairment in TBI: a longitudinal cohort study. Neurology 95, E2398–E2408 (2020).
pubmed: 32907958
pmcid: 7682912
doi: 10.1212/WNL.0000000000010825
Walker, W. C. et al. Global outcome and late seizures after penetrating versus closed traumatic brain injury: a NIDRR TBI Model Systems study. J. Head Trauma Rehabil. 30, 231–240 (2015).
pubmed: 25931183
doi: 10.1097/HTR.0000000000000127
Bushnik, T., Englander, J., Wright, J. & Kolakowsky-Hayner, S. A. Traumatic brain injury with and without late posttraumatic seizures: what are the impacts in the post-acute phase: a NIDRR traumatic brain injury model systems study. J. Head Trauma Rehabil. 27, 36–44 (2012).
doi: 10.1097/HTR.0b013e318273375c
Yu, T. et al. Predicting global functional outcomes among post-traumatic epilepsy patients after moderate-to-severe traumatic brain injury: development of a prognostic model. Front. Neurol. 13, 874491 (2022).
pubmed: 35711257
pmcid: 9197334
doi: 10.3389/fneur.2022.874491
Uski, J., Lamusuo, S., Teperi, S., Löyttyniemi, E. & Tenovuo, O. Mortality after traumatic brain injury and the effect of posttraumatic epilepsy. Neurology 91, e878–e883 (2018).
pubmed: 30068629
doi: 10.1212/WNL.0000000000006077
Karlander, M., Ljungqvist, J., Sörbo, A. & Zelano, J. Risk and cause of death in post-traumatic epilepsy: a register-based retrospective cohort study. J. Neurol. 269, 6014–6020 (2022).
pubmed: 35852600
pmcid: 9553825
doi: 10.1007/s00415-022-11279-5
Englander, J., Bushnik, T., Wright, J. M., Jamison, L. & Duong, T. T. Mortality in late post-traumatic seizures. J. Neurotrauma 26, 1471–1477 (2009).
pubmed: 19508123
pmcid: 2864464
doi: 10.1089/neu.2008.0729
Rayner, G., Jackson, G. D. & Wilson, S. J. Two distinct symptom-based phenotypes of depression in epilepsy yield specific clinical and etiological insights. Epilepsy Behav. 64, 336–344 (2016).
pubmed: 27473594
doi: 10.1016/j.yebeh.2016.06.007
Ponsford, J. Anxiety and depression following TBI. in Neurobehavioural Disability and Social Handicap Following Traumatic Brain Injury 2nd edn (eds McMillan, T. M. & Wood, R. L. L.) 167–177 (Taylor & Francis, 2017).
Foreman, B. et al. Seizures and cognitive outcome after traumatic brain injury: a post hoc analysis. Neurocrit. Care 36, 130–138 (2022).
pubmed: 34232458
doi: 10.1007/s12028-021-01267-4
Lee, H. et al. Continuous electroencephalography after moderate to severe traumatic brain injury. Crit. Care Med 47, 574–582 (2019).
pubmed: 30624278
pmcid: 6639805
doi: 10.1097/CCM.0000000000003639
He, X. et al. Resective surgery for drug-resistant posttraumatic epilepsy: predictors of seizure outcome. J. Neurosurg. 133, 1568–1575 (2019).
doi: 10.3171/2019.7.JNS191233
Chartrain, A. G. et al. Antiepileptics for post-traumatic seizure prophylaxis after traumatic brain injury. Curr. Pharm. Des. 23, 6428–6441 (2017).
pubmed: 29086674
doi: 10.2174/1381612823666171031100139
Zimmermann, L. L., Martin, R. M. & Girgis, F. Treatment options for posttraumatic epilepsy. Curr. Opin. Neurol. 30, 580–586 (2017).
pubmed: 29049053
doi: 10.1097/WCO.0000000000000505
Hamed, R., Hussein, R., Ibraheem, S. & Jumaily, M. Comparative study between leviteracetam, phenytoin & carbamazepine in treating post traumatic epilepsy. NeuroQuantology 18, 1–5 (2020).
doi: 10.14704/nq.2020.18.10.NQ20225
Scheffer, I. E. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58, 512–521 (2017).
pubmed: 28276062
pmcid: 5386840
doi: 10.1111/epi.13709
Hitti, F. L. et al. Surgical outcomes in post-traumatic epilepsy: a single institutional experience. Oper. Neurosurg. 18, 12–18 (2020).
doi: 10.1093/ons/opz043
Marks, D. A., Kim, J., Spencer, D. D. & Spencer, S. S. Seizure localization and pathology following head injury in patients with uncontrolled epilepsy. Neurology 45, 2051–2057 (1995).
pubmed: 7501158
doi: 10.1212/WNL.45.11.2051
Hakimian, S. et al. Long-term outcome of extratemporal resection in posttraumatic epilepsy. Neurosurg. Focus 32, E10 (2012).
pubmed: 22380851
doi: 10.3171/2012.1.FOCUS11329
Schuele, S. U. & Lüders, H. O. Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol. 7, 514–524 (2008).
pubmed: 18485315
doi: 10.1016/S1474-4422(08)70108-X
Ferreira, L. D., Tabaeizadeh, M. & Haneef, Z. Surgical outcomes in post-traumatic temporal lobe epilepsy: a systematic review and meta-analysis. J. Neurotrauma 41, 319–330 (2024).
pubmed: 37658840
doi: 10.1089/neu.2023.0084
Wiebe, S., Blume, W. T., Girvin, J. P. & Eliasziw, M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med. 345, 311–318 (2001).
pubmed: 11484687
doi: 10.1056/NEJM200108023450501
Lee, H.-O. et al. Effect of vagus nerve stimulation in post-traumatic epilepsy and failed epilepsy surgery: preliminary report. J. Korean Neurosurg. Soc. 44, 196–198 (2008).
pubmed: 19096676
pmcid: 2588308
doi: 10.3340/jkns.2008.44.4.196
Shen, C.-C. & Jiang, J.-F. Auricular electroacupuncture for late posttraumatic epilepsy after severe brain injury: a retrospective study. Evid. Based Complement Altern. Med. 2019, 5798912 (2019).
doi: 10.1155/2019/5798912
Chen, Y. et al. Quantitative epileptiform burden and electroencephalography background features predict post-traumatic epilepsy. J. Neurol. Neurosurg. Psychiatry 94, 245–249 (2023).
pubmed: 36241423
doi: 10.1136/jnnp-2022-329542
Kim, J. A. et al. Epileptiform activity in traumatic brain injury predicts post-traumatic epilepsy. Ann. Neurol. 83, 858–862 (2018).
pubmed: 29537656
pmcid: 5912971
doi: 10.1002/ana.25211
Faghihpirayesh, R. et al. Automatic detection of EEG epileptiform abnormalities in traumatic brain injury using deep learning. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2021, 302–305 (2021).
pubmed: 34891296
pmcid: 8860400
Di Sapia, R. et al. ECoG spiking activity and signal dimension are early predictive measures of epileptogenesis in a translational mouse model of traumatic brain injury. Neurobiol. Dis. 185, 106251 (2023).
pubmed: 37536383
doi: 10.1016/j.nbd.2023.106251
Kumar, U., Li, L., Bragin, A. & Engel, J. J. Spike and wave discharges and fast ripples during posttraumatic epileptogenesis. Epilepsia 62, 1842–1851 (2021).
pubmed: 34155626
pmcid: 8349888
doi: 10.1111/epi.16958
Li, L. et al. Spatial and temporal profile of high-frequency oscillations in posttraumatic epileptogenesis. Neurobiol. Dis. 161, 105544 (2021).
pubmed: 34742877
pmcid: 9075674
doi: 10.1016/j.nbd.2021.105544
Pease, M. et al. Predicting post-traumatic epilepsy using admission electroencephalography after severe traumatic brain injury. Epilepsia 64, 1842–1852 (2023).
pubmed: 37073101
doi: 10.1111/epi.17622
Ghaith, H. S. et al. A literature review of traumatic brain injury biomarkers. Mol. Neurobiol. 59, 4141–4158 (2022).
pubmed: 35499796
pmcid: 9167167
doi: 10.1007/s12035-022-02822-6
Misra, S. et al. Common pathways of epileptogenesis in patients with epilepsy post-brain injury: findings from a systematic review and meta-analysis. Neurology 101, e2243–e2256 (2023).
pubmed: 37550071
doi: 10.1212/WNL.0000000000207749
Cotter, D., Kelso, A. & Neligan, A. Genetic biomarkers of posttraumatic epilepsy: a systematic review. Seizure 46, 53–58 (2017).
pubmed: 28242442
doi: 10.1016/j.seizure.2017.02.002
Nam, J.-W. et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol. Cell 53, 1031–1043 (2014).
pubmed: 24631284
pmcid: 4062300
doi: 10.1016/j.molcel.2014.02.013
Yu, Y. et al. The role of exosomal microRNAs in central nervous system diseases. Mol. Cell. Biochem. 476, 2111–2124 (2021).
pubmed: 33528706
doi: 10.1007/s11010-021-04053-0
Gitaí, D. L. G. et al. Extracellular vesicles in the forebrain display reduced miR-346 and miR-331-3p in a rat model of chronic temporal lobe epilepsy. Mol. Neurobiol. 57, 1674–1687 (2020).
pubmed: 31813125
doi: 10.1007/s12035-019-01797-1
Chen, S.-D. et al. Circulating microRNAs from serum exosomes may serve as a putative biomarker in the diagnosis and treatment of patients with focal cortical dysplasia. Cells 9, 1867 (2020).
pubmed: 32785072
pmcid: 7465068
doi: 10.3390/cells9081867
Brennan, G. P. & Henshall, D. C. microRNAs in the pathophysiology of epilepsy. Neurosci. Lett. 667, 47–52 (2018).
pubmed: 28104433
doi: 10.1016/j.neulet.2017.01.017
Wang, Y. et al. Circulating microRNAs from plasma small extracellular vesicles as potential diagnostic biomarkers in pediatric epilepsy and drug-resistant epilepsy. Front. Mol. Neurosci. 15, 823802 (2022).
pubmed: 35221916
pmcid: 8866954
doi: 10.3389/fnmol.2022.823802
Heiskanen, M. et al. Discovery and validation of circulating microRNAs as biomarkers for epileptogenesis after experimental traumatic brain injury — the EPITARGET Cohort. Int. J. Mol. Sci. 24, 2823 (2023).
pubmed: 36769143
pmcid: 9918096
doi: 10.3390/ijms24032823
Kumar, P. miRNA dysregulation in traumatic brain injury and epilepsy: a systematic review to identify putative biomarkers for post-traumatic epilepsy. Metab. Brain Dis. 38, 749–765 (2023).
pubmed: 36715879
doi: 10.1007/s11011-023-01172-z
Karnati, H. K. et al. Neuronal enriched extracellular vesicle proteins as biomarkers for traumatic brain injury. J. Neurotrauma 36, 975–987 (2019).
pubmed: 30039737
pmcid: 6444902
doi: 10.1089/neu.2018.5898
Lin, Z. et al. Serum exosomal proteins F9 and TSP-1 as potential diagnostic biomarkers for newly diagnosed epilepsy. Front. Neurosci. 14, 737 (2020).
pubmed: 32848539
pmcid: 7417627
doi: 10.3389/fnins.2020.00737
Karttunen, J., Heiskanen, M., Lipponen, A., Poulsen, D. & Pitkänen, A. Extracellular vesicles as diagnostics and therapeutics for structural epilepsies. Int. J. Mol. Sci. 20, 1259 (2019).
pubmed: 30871144
pmcid: 6470789
doi: 10.3390/ijms20061259
Upadhya, D. & Shetty, A. K. Promise of extracellular vesicles for diagnosis and treatment of epilepsy. Epilepsy Behav. 121, 106499 (2021).
pubmed: 31636006
doi: 10.1016/j.yebeh.2019.106499
Redell, J. B., Moore, A. N., Ward, N. H. III, Hergenroeder, G. W. & Dash, P. K. Human traumatic brain injury alters plasma microRNA levels. J. Neurotrauma 27, 2147–2156 (2010).
pubmed: 20883153
pmcid: 6468948
doi: 10.1089/neu.2010.1481
Qin, X. et al. Expression profile of plasma microRNAs and their roles in diagnosis of mild to severe traumatic brain injury. PLoS ONE 13, e0204051 (2018).
pubmed: 30226895
pmcid: 6143266
doi: 10.1371/journal.pone.0204051
Ko, J. et al. Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesicles. Lab Chip 18, 3617–3630 (2018).
pubmed: 30357245
pmcid: 6334845
doi: 10.1039/C8LC00672E
Hicks, S. D. et al. Overlapping microRNA expression in saliva and cerebrospinal fluid accurately identifies pediatric traumatic brain injury. J. Neurotrauma 35, 64–72 (2018).
pubmed: 28762893
pmcid: 7227420
doi: 10.1089/neu.2017.5111
Di Pietro, V. et al. MicroRNAs as novel biomarkers for the diagnosis and prognosis of mild and severe traumatic brain injury. J. Neurotrauma 34, 1948–1956 (2017).
pubmed: 28279125
doi: 10.1089/neu.2016.4857
Bhomia, M., Balakathiresan, N. S., Wang, K. K., Papa, L. & Maheshwari, R. K. A panel of serum miRNA biomarkers for the diagnosis of severe to mild traumatic brain injury in humans. Sci. Rep. 6, 28148 (2016).
pubmed: 27338832
pmcid: 4919667
doi: 10.1038/srep28148
Yan, S. et al. Altered microRNA profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis. Oncotarget 8, 4136–4146 (2017).
pubmed: 27926529
doi: 10.18632/oncotarget.13744
Raoof, R. et al. Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy. eBioMedicine 38, 127–141 (2018).
pubmed: 30396857
pmcid: 6306312
doi: 10.1016/j.ebiom.2018.10.068
Medel-Matus, J.-S. et al. Susceptibility to epilepsy after traumatic brain injury is associated with preexistent gut microbiome profile. Epilepsia 63, 1835–1848 (2022).
pubmed: 35366338
pmcid: 9656503
doi: 10.1111/epi.17248
Medel-Matus, J.-S. et al. Modification of post-traumatic epilepsy by fecal microbiota transfer. Epilepsy Behav. 134, 108860 (2022).
pubmed: 35914438
doi: 10.1016/j.yebeh.2022.108860
French, J. A. et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann. Neurol. 34, 774–780 (1993).
pubmed: 8250525
doi: 10.1002/ana.410340604
Löscher, W. The search for new screening models of pharmacoresistant epilepsy: is induction of acute seizures in epileptic rodents a suitable approach? Neurochem. Res. 42, 1926–1938 (2017).
pubmed: 27502939
doi: 10.1007/s11064-016-2025-7
Dudek, F. E. & Staley, K. J. The time course and circuit mechanisms of acquired epileptogenesis. in Jasper’s Basic Mechanisms of the Epilepsies 4th edn (eds Noebels, J. L. et al.) (Oxford Univ. Press, 2012).
Santhakumar, V., Ratzliff, A. D., Jeng, J., Toth, Z. & Soltesz, I. Long-term hyperexcitability in the hippocampus after experimental head trauma. Ann. Neurol. 50, 708–717 (2001).
pubmed: 11761468
doi: 10.1002/ana.1230
Dudek, F. E. & Spitz, M. Hypothetical mechanisms for the cellular and neurophysiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization. J. Clin. Neurophysiol. 14, 90–101 (1997).
pubmed: 9165404
doi: 10.1097/00004691-199703000-00002
Cantu, D. et al. Traumatic brain injury increases cortical glutamate network activity by compromising GABAergic control. Cereb. Cortex 25, 2306–2320 (2015).
pubmed: 24610117
doi: 10.1093/cercor/bhu041
Lowenstein, D. H., Thomas, M. J., Smith, D. H. & McIntosh, T. K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12, 4846–4853 (1992).
pubmed: 1464770
pmcid: 6575779
doi: 10.1523/JNEUROSCI.12-12-04846.1992
Raible, D. J., Frey, L. C., Cruz Del Angel, Y., Russek, S. J. & Brooks-Kayal, A. R. GABA(A) receptor regulation after experimental traumatic brain injury. J. Neurotrauma 29, 2548–2554 (2012).
pubmed: 22827467
pmcid: 3495117
doi: 10.1089/neu.2012.2483
Gupta, A., Elgammal, F. S., Proddutur, A., Shah, S. & Santhakumar, V. Decrease in tonic inhibition contributes to increase in dentate semilunar granule cell excitability after brain injury. J. Neurosci. 32, 2523–2537 (2012).
pubmed: 22396425
pmcid: 6621807
doi: 10.1523/JNEUROSCI.4141-11.2012
Webster, K. M. et al. Inflammation in epileptogenesis after traumatic brain injury. J. Neuroinflammation 14, 10 (2017).
pubmed: 28086980
pmcid: 5237206
doi: 10.1186/s12974-016-0786-1
Hunt, R. F., Scheff, S. W. & Smith, B. N. Synaptic reorganization of inhibitory hilar interneuron circuitry after traumatic brain injury in mice. J. Neurosci. 31, 6880–6890 (2011).
pubmed: 21543618
pmcid: 3102318
doi: 10.1523/JNEUROSCI.0032-11.2011
Bolkvadze, T., Puhakka, N. & Pitkänen, A. Epileptogenesis after traumatic brain injury in Plaur-deficient mice. Epilepsy Behav. 60, 187–196 (2016).
pubmed: 27208924
doi: 10.1016/j.yebeh.2016.04.038
Kumar, P. et al. Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling. Nat. Neurosci. 25, 956–966 (2022).
pubmed: 35739273
pmcid: 9276529
doi: 10.1038/s41593-022-01095-5
Srinivasan, D., Yen, J.-H., Joseph, D. J. & Friedman, W. Cell type-specific interleukin-1beta signaling in the CNS. J. Neurosci. 24, 6482–6488 (2004).
pubmed: 15269258
pmcid: 6729878
doi: 10.1523/JNEUROSCI.5712-03.2004
Shiozaki, T. et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23, 406–410 (2005).
pubmed: 15834305
doi: 10.1097/01.shk.0000161385.62758.24
Fan, L. et al. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res. Mol. Brain Res. 30, 125–130 (1995).
pubmed: 7609633
doi: 10.1016/0169-328X(94)00287-O
Clausen, F. et al. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 30, 385–396 (2009).
pubmed: 19614750
doi: 10.1111/j.1460-9568.2009.06820.x
Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191–195 (2002).
pubmed: 12110890
doi: 10.1038/nature00858
Shi, Y., Zhang, L., Teng, J. & Miao, W. HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy. Mol. Med. Rep. 17, 5125–5131 (2018).
pubmed: 29393419
pmcid: 5865977
Chiavegato, A., Zurolo, E., Losi, G., Aronica, E. & Carmignoto, G. The inflammatory molecules IL-1β and HMGB1 can rapidly enhance focal seizure generation in a brain slice model of temporal lobe epilepsy. Front. Cell. Neurosci. 8, 155 (2014).
pubmed: 24936172
pmcid: 4047964
doi: 10.3389/fncel.2014.00155
Semple, B. D., Kossmann, T. & Morganti-Kossmann, M. C. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 30, 459–473 (2010).
pubmed: 19904283
doi: 10.1038/jcbfm.2009.240
Gosselin, R. D. et al. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J. Neurochem. 95, 1023–1034 (2005).
pubmed: 16150057
doi: 10.1111/j.1471-4159.2005.03431.x
Patabendige, A. & Janigro, D. The role of the blood–brain barrier during neurological disease and infection. Biochem. Soc. Trans. 51, 613–626 (2023).
pubmed: 36929707
pmcid: 10212550
doi: 10.1042/BST20220830
Marchi, N., Granata, T., Alexopoulos, A. & Janigro, D. The blood–brain barrier hypothesis in drug resistant epilepsy. Brain 135, e211 (2012).
pubmed: 22252997
pmcid: 3326249
doi: 10.1093/brain/awr343
Bargerstock, E. et al. Is peripheral immunity regulated by blood–brain barrier permeability changes? PLoS ONE 9, e101477 (2014).
pubmed: 24988410
pmcid: 4079719
doi: 10.1371/journal.pone.0101477
Dadas, A. & Janigro, D. Breakdown of blood–brain barrier as a mechanism of post-traumatic epilepsy. Neurobiol. Dis. 123, 20–26 (2019).
pubmed: 30030025
doi: 10.1016/j.nbd.2018.06.022
Weissberg, I. et al. Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood–brain barrier dysfunction. Neurobiol. Dis. 78, 115–125 (2015).
pubmed: 25836421
pmcid: 4426044
doi: 10.1016/j.nbd.2015.02.029
Ivens, S. et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130, 535–547 (2007).
pubmed: 17121744
doi: 10.1093/brain/awl317
Saletti, P. G. et al. In search of antiepileptogenic treatments for post-traumatic epilepsy. Neurobiol. Dis. 123, 86–99 (2019).
pubmed: 29936231
doi: 10.1016/j.nbd.2018.06.017
Kendirli, M. T., Rose, D. T. & Bertram, E. H. A model of posttraumatic epilepsy after penetrating brain injuries: effect of lesion size and metal fragments. Epilepsia 55, 1969–1977 (2014).
pubmed: 25470332
pmcid: 4285662
doi: 10.1111/epi.12854
Takei, N. & Nawa, H. mTOR signaling and its roles in normal and abnormal brain development. Front. Mol. Neurosci. 7, 28 (2014).
pubmed: 24795562
pmcid: 4005960
doi: 10.3389/fnmol.2014.00028
Lee, D. Y. Roles of mTOR signaling in brain development. Exp. Neurobiol. 24, 177–185 (2015).
pubmed: 26412966
pmcid: 4580744
doi: 10.5607/en.2015.24.3.177
Butler, C. R., Boychuk, J. A. & Smith, B. N. Effects of rapamycin treatment on neurogenesis and synaptic reorganization in the dentate gyrus after controlled cortical impact injury in mice. Front. Syst. Neurosci. 9, 163 (2015).
pubmed: 26640431
pmcid: 4661228
doi: 10.3389/fnsys.2015.00163
Niu, L.-J., Xu, R.-X., Zhang, P., Du, M.-X. & Jiang, X.-D. Suppression of Frizzled-2-mediated Wnt/Ca
pubmed: 22521824
doi: 10.1016/j.neuroscience.2012.03.057
Mardones, M. D. & Gupta, K. Transcriptome profiling of the hippocampal seizure network implicates a role for Wnt signaling during epileptogenesis in a mouse model of temporal lobe epilepsy. Int. J. Mol. Sci. 23, 12030 (2022).
pubmed: 36233336
pmcid: 9569502
doi: 10.3390/ijms231912030
Gupta, K. & Schnell, E. Neuronal network remodeling and Wnt pathway dysregulation in the intra-hippocampal kainate mouse model of temporal lobe epilepsy. PLoS ONE 14, e0215789 (2019).
pubmed: 31596871
pmcid: 6785072
doi: 10.1371/journal.pone.0215789
Raza, M. et al. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl Acad. Sci. USA 101, 17522–17527 (2004).
pubmed: 15583136
pmcid: 535000
doi: 10.1073/pnas.0408155101
Powell, K. L., Cain, S. M., Snutch, T. P. & O’Brien, T. J. Low threshold T-type calcium channels as targets for novel epilepsy treatments. Br. J. Clin. Pharm. 77, 729–739 (2014).
doi: 10.1111/bcp.12205
Conboy, K., Henshall, D. C. & Brennan, G. P. Epigenetic principles underlying epileptogenesis and epilepsy syndromes. Neurobiol. Dis. 148, 105179 (2021).
pubmed: 33181318
doi: 10.1016/j.nbd.2020.105179
Dębski, K. J. et al. Etiology matters — genomic DNA methylation patterns in three rat models of acquired epilepsy. Sci. Rep. 6, 25668 (2016).
pubmed: 27157830
pmcid: 4860710
doi: 10.1038/srep25668
Nelson, E. D., Kavalali, E. T. & Monteggia, L. M. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J. Neurosci. 28, 395–406 (2008).
pubmed: 18184782
pmcid: 6670512
doi: 10.1523/JNEUROSCI.3796-07.2008
Machnes, Z. M. et al. DNA methylation mediates persistent epileptiform activity in vitro and in vivo. PLoS ONE 8, e76299 (2013).
pubmed: 24098468
pmcid: 3788713
doi: 10.1371/journal.pone.0076299
Deutsch, S. I., Mastropaolo, J., Burket, J. A. & Rosse, R. B. An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam’s antiseizure efficacy in the mouse. Eur. Neuropsychopharmacol. 19, 398–401 (2009).
pubmed: 19189880
doi: 10.1016/j.euroneuro.2008.12.011
Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10, 973–976 (2013).
pubmed: 23892895
pmcid: 3911785
doi: 10.1038/nmeth.2600
Dominguez, A. A., Lim, W. A. & Qi, L. S. Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat. Rev. Mol. Cell Biol. 17, 5–15 (2016).
pubmed: 26670017
doi: 10.1038/nrm.2015.2
Sasa, M. A new frontier in epilepsy: novel antiepileptogenic drugs. J. Pharmacol. Sci. 100, 487–494 (2006).
pubmed: 16799261
doi: 10.1254/jphs.CPJ06010X
Brady, R. D. et al. Modelling traumatic brain injury and posttraumatic epilepsy in rodents. Neurobiol. Dis. 123, 8–19 (2020).
doi: 10.1016/j.nbd.2018.08.007
Ford, I. & Norrie, J. Pragmatic trials. N. Engl. J. Med. 375, 454–463 (2016).
pubmed: 27518663
doi: 10.1056/NEJMra1510059
Casey, J. D., Beskow, L. M. & Brown, J. Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19. Lancet Respir. Med. 10, 700–714 (2022).
pubmed: 35709825
pmcid: 9191864
doi: 10.1016/S2213-2600(22)00044-3
Braun, R. It’s been a TRACK-TBI LONG time coming but well worth the wait. Neurology 101, 287–289 (2023).
pubmed: 37344227
doi: 10.1212/WNL.0000000000207682
McCrea, M. A. et al. Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, longitudinal TRACK-TBI study. JAMA Neurol. 78, 982–992 (2021).
pubmed: 34228047
pmcid: 8261688
doi: 10.1001/jamaneurol.2021.2043
Andrews, P. J. et al. Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT. Health Technol. Assess. 22, 1–134 (2018).
pubmed: 30168413
pmcid: 6139479
doi: 10.3310/hta22450
Bastian, L. A. et al. Stakeholder engagement in pragmatic clinical trials: emphasizing relationships to improve pain management delivery and outcomes. Pain Med. 21, S13–S20 (2020).
pubmed: 33313726
pmcid: 7824996
doi: 10.1093/pm/pnaa333
Morain, S. & Largent, E. Think pragmatically: investigators’ obligations to patient-subjects when research is embedded in care. Am. J. Bioeth. 23, 10–21 (2023).
pubmed: 35435790
doi: 10.1080/15265161.2022.2063435
Diaz, V. Encouraging participation of minorities in research studies. Ann. Fam. Med. 10, 372–373 (2012).
pubmed: 22778129
pmcid: 3392301
doi: 10.1370/afm.1426
Boden-Albala, B. et al. Use of community-engaged research approaches in clinical interventions for neurologic disorders in the United States. Neurology 101, S27–S46 (2023).
pubmed: 37580148
doi: 10.1212/WNL.0000000000207563
Griffith, D. M., Towfighi, A., Manson, S. M., Littlejohn, E. L. & Skolarus, L. E. Determinants of inequities in neurologic disease, health, and well-being: the NINDS Social Determinants of Health Framework. Neurology 101, S75–S81 (2023).
pubmed: 37580154
doi: 10.1212/WNL.0000000000207566
Danziger, J. et al. Temporal trends in critical care outcomes in U.S. minority-serving hospitals. Am. J. Respir. Crit. Care Med 201, 681–687 (2020).
pubmed: 31948262
pmcid: 7263391
doi: 10.1164/rccm.201903-0623OC
Kanter, G. P., Segal, A. G. & Groeneveld, P. W. Income disparities in access to critical care services. Health Aff. 39, 1362–1367 (2020).
doi: 10.1377/hlthaff.2020.00581
Nayfeh, A. & Fowler, R. A. Understanding patient- and hospital-level factors leading to differences, and disparities, in critical care. Am. J. Respir. Crit. Care Med 201, 642–644 (2020).
pubmed: 32011903
pmcid: 7068824
doi: 10.1164/rccm.202001-0116ED
Brown, K. E., Fohner, A. E. & Woodahl, E. L. Beyond the individual: community-centric approaches to increase diversity in biomedical research. Clin. Pharmacol. Ther. 113, 509–517 (2023).
pubmed: 36448873
doi: 10.1002/cpt.2808
Benizri, N., Hallot, S., Burns, K. & Goldfarb, M. Patient and family representation in randomized clinical trials published in 3 medical and surgical journals: a systematic review. JAMA Netw. Open 5, e2230858 (2022).
pubmed: 36083584
pmcid: 9463605
doi: 10.1001/jamanetworkopen.2022.30858
Gill, M. et al. Patient and family member-led research in the intensive care unit: a novel approach to patient-centered research. PLoS ONE 11, e0160947 (2016).
pubmed: 27494396
pmcid: 4975402
doi: 10.1371/journal.pone.0160947
Fairley, R. et al. Increasing clinical trial participation of Black women diagnosed with breast cancer. J. Racial Ethn. Health Disparities https://doi.org/10.1007/s40615-023-01644-z (2023).
doi: 10.1007/s40615-023-01644-z
pubmed: 37314691
Barrett, N. J. et al. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers. Cancer 126, 1077–1089 (2020).
pubmed: 31909824
doi: 10.1002/cncr.32487
Miles, S. R. et al. Evolution of irritability, anger, and aggression after traumatic brain injury: identifying and predicting subgroups. J. Neurotrauma 38, 1827–1833 (2021).
pubmed: 33470179
pmcid: 8881953
doi: 10.1089/neu.2020.7451
Driver, S., Reynolds, M. & Kramer, K. Modifying an evidence-based lifestyle programme for individuals with traumatic brain injury. Brain Inj. 31, 1612–1616 (2017).
pubmed: 28750178
doi: 10.1080/02699052.2017.1346286
Sutton, K. M. et al. Engaging individuals with neurological conditions and caregivers in rural communities in a health research team. Prog. Community Health Partnersh. 13, 129–139 (2019).
pubmed: 31178448
doi: 10.1353/cpr.2019.0027
Shimia, M. et al. A placebo-controlled randomized clinical trial of amantadine hydrochloride for evaluating the functional improvement of patients following severe acute traumatic brain injury. J. Neurosurg. Sci. 67, 598–604 (2023).
pubmed: 34114429
doi: 10.23736/S0390-5616.21.05266-8
Morey, C. E., Cilo, M., Berry, J. & Cusick, C. The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. Brain Inj. 17, 809–815 (2003).
pubmed: 12850946
doi: 10.1080/0269905031000088586
Jha, A. et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J. Head Trauma Rehabil. 23, 52–63 (2008).
pubmed: 18219235
doi: 10.1097/01.HTR.0000308721.77911.ea
Shultz, S. R. et al. Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury. Brain 138, 1297–1313 (2015).
pubmed: 25771151
pmcid: 5963409
doi: 10.1093/brain/awv053
Liu, S.-J. et al. Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau. Brain 139, 1919–1938 (2016).
pubmed: 27289302
doi: 10.1093/brain/aww116
Li, Z. et al. Iron neurotoxicity and protection by deferoxamine in intracerebral hemorrhage. Front. Mol. Neurosci. 15, 927334 (2022).
pubmed: 35782383
pmcid: 9245523
doi: 10.3389/fnmol.2022.927334
Terrone, G., Balosso, S., Pauletti, A., Ravizza, T. & Vezzani, A. Inflammation and reactive oxygen species as disease modifiers in epilepsy. Neuropharmacology 167, 107742 (2020).
pubmed: 31421074
doi: 10.1016/j.neuropharm.2019.107742
Serrano, G. E. et al. Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J. Neurosci. 31, 14850–14860 (2011).
pubmed: 22016518
pmcid: 4126152
doi: 10.1523/JNEUROSCI.3922-11.2011
Desjardins, P. et al. Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem. Int. 42, 299–303 (2003).
pubmed: 12470703
doi: 10.1016/S0197-0186(02)00101-8
Löscher, W. & Friedman, A. Structural, molecular, and functional alterations of the blood–brain barrier during epileptogenesis and epilepsy: a cause, consequence, or both? Int. J. Mol. Sci. 21, 591 (2020).
pubmed: 31963328
pmcid: 7014122
doi: 10.3390/ijms21020591
Henshall, D. C. & Kobow, K. Epigenetics and epilepsy. Cold Spring Harb. Perspect. Med. 5, a022731 (2015).
pubmed: 26438606
pmcid: 4665035
doi: 10.1101/cshperspect.a022731
Guo, D., Zeng, L., Brody, D. L. & Wong, M. Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS ONE 8, e64078 (2013).
pubmed: 23691153
pmcid: 3653881
doi: 10.1371/journal.pone.0064078
Galanopoulou, A. S., Gorter, J. A. & Cepeda, C. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia 53, 1119–1130 (2012).
pubmed: 22578218
pmcid: 3389589
doi: 10.1111/j.1528-1167.2012.03506.x
Coulter, D. A. & Steinhäuser, C. Role of astrocytes in epilepsy. Cold Spring Harb. Perspect. Med. 5, a022434 (2015).
pubmed: 25732035
pmcid: 4355248
doi: 10.1101/cshperspect.a022434